LAMEA Contrast Injector Systems Market By Application (Radiology, Interventional Radiology, Interventional Cardiology), Product (Injector - CT Injector Systems, MRI Injector Systems, Angiography Injector Systems; Consumables - Syringes, Injector Head, Tubing) Consumables; Accessories), End User (Hospitals, Diagnostics)

Analysis of Market Size & Trends

The Latin America, Middle East and Africa Contrast Injector Systems Market would witness market growth of 9.5% CAGR during the forecast period (2018 – 2024). Contrast injector systems are medical devices which use contrast media to improve the visibility of complex body structures, namely body fluids, tissues, arteries, and veins. The diagnostic process is conducted using various imaging procedures such as computed tomography (CT), magnetic resonance imaging (MRI), and angiography. Advanced healthcare spaces are swiftly adopting contrast injector techniques mainly because injector systems offer comprehensive imagery by way of computed tomography (CT), magnetic resonance imaging (MRI), angiography, and others. Technological innovations help with the development of inexpensive and entirely automated contrast injector approaches. These kinds of automated contrast injectors support radiologist and other healthcare practitioners in reducing the odds of human error and making it possible for customized patient treatment. Nevertheless, the high-priced contrast injector systems combined with the hazards involved with contrast media impede the market expansion.

Click Here For Free Insights

Based on Application, the market is segmented into Geospatial Mapping, Disaster Management, Energy & Resource Management, Surveillance & Monitoring, and Others. Based on End User, the market is segmented into Government, Energy, Defense, Agriculture & Forestry, Media & Entertainment, Civil Engineering & Archaeology, and Others. Based on countries, the market is segmented into Brazil, Argentina, UAE, Saudi Arabia, South Africa, Nigeria, and Rest of LAMEA.

The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Bayer AG, Angiodynamics Inc., GE Healthcare (A Healthcare Division of GE Company), Medtron AG, Nemoto Kyorindo Co., Ltd., Sino Medical- Device Technology Co., Ltd., Shenzhen Seacrown Electromechanical Co., Ltd., Ulrich GmbH & Co. Kg, Vivid Imaging and Guerbet Group.

Scope of the Study

Market Segmentation:

By Application

• Radiology
• Interventional Radiology
• Interventional Cardiology

By Product

• Injector

• CT Injector Systems
• MRI Injector Systems
• Angiography Injector Systems

• Consumables

• Syringes
• Injector Head
• Tubing
• Others

• Accessories

By End User

• Hospitals
• Diagnostics

• Other

By Country

• Brazil
• Argentina
• UAE
• Saudi Arabia
• South Africa
• Nigeria
• Rest of LAMEA

Companies Profiled

• Bayer AG
• Angiodynamics Inc.
• GE Healthcare (A Healthcare Division of GE Company)
• Medtron AG
• Nemoto Kyorindo Co., Ltd.
• Sino Medical- Device Technology Co., Ltd.
• Shenzhen Seacrown Electromechanical Co., Ltd.
• Ulrich GmbH & Co. Kg
• Vivid Imaging
• Guerbet Group